No Recent News for the Company
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter Ended 30 June 2026.
07-Aug-2026 | Source : BSEMedicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Unaudited Financial Results for the quarter ended 30 June 2026.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
28-Jul-2026 | Source : BSECompliance Certificate under Reg 74(5) of SEBI (DP) Regulations 2018
Closure of Trading Window
25-Jun-2026 | Source : BSEIntimation for closure of trading window
Corporate Actions
14 Aug 2026
Medicamen Biotech Ltd has declared 10% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available